Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Radiat Res. 2012 Aug 2;178(4):266–279. doi: 10.1667/rr2845.1

TABLE 3.

Numbers of Deaths Due to Cancer of Selected Organs and Lymphatic/Hematopoietic Cancers, Standardized Mortality Ratios (External Comparisons), by Treatment and Relative Risks (Internal Comparisons)

No radiotherapy
Any radiotherapy
ICD8 Cause of death n a SMRb 95% CIc n a SMRb 95% CIc RRd 95% CIc
Number of women: 3,186 9,769
Person-years: 101,816 288,589
10–999 All causes 2,191 0.9 0.8–0.9 7,162 0.9 0.9–0.9 1.1 1.1–1.2
140–199 All solid cancers 353 0.8 0.8–0.9 1,395 1.1 1.1–1.2 1.3 1.2–1.5
Heavily-irradiated sites (>1 Gy) 109 0.7 0.6–0.8 690 1.4 1.3–1.5 1.9 1.6–2.4
 180–180 Uterine cervix 14 0.7 0.4–1.2 65 0.9 0.7–1.1 1.2 0.7–2.3
 181–182 Uterine corpus 15 0.7 0.4–1.2 217 2.9 2.6–3.3 3.7 2.3–6.5
 188 Bladder 5 0.5 0.2–1.1 48 1.6 1.2–2.1 3.2 1.4–9.2
 154 Rectum 4 0.3 0.1–0.6 51 1.0 0.7–1.3 4.1 1.7–13.8
 183 Ovary 21 0.8 0.5–1.1 105 1.3 1.1–1.6 1.8 1.1–3.0
 184 Other female genital organs 6 2.0 0.8–4.1 10 1.1 0.5–1.9 0.6 0.2–1.7
 153 Colon 50 0.8 0.6–1.0 204 1.1 0.9–1.2 1.4 1.1–2.0
Lightly-irradiated sites (0.1–1 Gy)
 155–156 Liver, gallbladder and bile ducts 14 0.9 0.5–1.4 42 0.7 0.5–1.0 0.9 0.5–1.8
 151 Stomach 19 0.8 0.5–1.2 68 0.8 0.6–1.0 1.0 0.6–1.8
 189 Kidney 9 1.2 0.6–2.2 24 1.2 0.8–1.7 0.8 0.4–1.9
 157 Pancreas 26 1.0 0.7–1.5 74 1.0 0.8–1.3 1.1 0.7–1.9
Very lightly-irradiated sites (<0.1 Gy)
 162 Lung 42 1.0 0.7–1.3 84 1.0 0.8–1.3 1.1 0.7–1.6
 174 Breast 75 0.9 0.7–1.1 194 0.8 0.7–1.0 1.0 0.7–1.3
 150 Esophagus 1 0.2 0.0–1.0 10 0.8 0.4–1.4 e
 193 Thyroid 2 0.9 0.2–2.8 5 0.7 0.2–1.5 e
 140 Buccal cavity and pharynx 4 0.7 0.2–1.6 11 0.7 0.4–1.2 1.0 0.3–3.6
 191 Brain 3 0.6 0.2–1.6 20 2.3 1.4–3.5 e
Bone and connective tissue cancers
 170 Bone 1 0.5 0.0–2.3 4 0.6 0.2–1.3 e
 171 Connective tissues 1 0.6 0.0–2.5 6 1.4 0.5–2.8 e
Lymphatic/Hematopoietic cancers
 200, 202 Non-Hodgkin lymphoma 20 1.4 0.9–2.2 48 1.3 1.0–1.7 0.9 0.5–1.6
 201 Hodgkin lymphoma 4 1.6 0.5–3.8 9 1.1 0.5–2.0 0.7 0.2–2.6
 203 Multiple myeloma 8 1.2 0.5–2.2 18 1.0 0.6–1.6 0.9 0.4–2.1
 204–207 Leukemia 10 0.6 0.3–1.1 70 1.5 1.1–1.8 2.4 1.3–4.9
 204.0, 205–207 Non-CLLf leukemia 3 0.2 0.1–0.6 51 1.4 1.1–1.8 e
 205 Myeloid leukemia 3g 0.5 0.1–1.3 28h 1.6 1.1–2.3 e
204.1, 204.9 Lymphocytic leukemia 7 1.8 0.8–3.7 19 1.6 1.0–2.5 0.9 0.4–2.3
a

Number of deaths.

b

Standardized mortality ratio.

c

95% confidence interval.

d

Relative risk of mortality (relative risks and 95% confidence intervals for lymphatic/hematopoietic cancers were calculated based on standardized mortality rate regression).

e

Relative risk and 95% confidence intervals were not presented due to small number of deaths among no RT group.

f

Chronic lymphocytic leukemia.

g

Two acute myeloid leukemia and 1 not other specified.

h

Twelve acute myeloid leukemia, 12 chronic myeloid leukemia and 4 not other specified.